Eugene Bauer - 08 Dec 2025 Form 4 Insider Report for Evommune, Inc.

Role
Chief Medical Officer, Director
Signature
/s/ Gregory S. Moss, Attorney-in-Fact
Issuer symbol
EVMN on NYSE
Transactions as of
08 Dec 2025
Net transactions value
$0
Form type
4
Filing time
19 Dec 2025, 16:06:11 UTC
Previous filing
12 Nov 2025
Next filing
11 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Bauer Eugene Chief Medical Officer, Director C/O EVOMMUNE, INC., 1841 PAGE MILL ROAD, SUITE 100, PALO ALTO /s/ Gregory S. Moss, Attorney-in-Fact 19 Dec 2025 0001678620

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EVMN Employee Stock Option (Right to Buy) Award $0 +100,000 $0.000000 100,000 08 Dec 2025 Common Stock 100,000 $18.44 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One fourth (1/4) of the shares subject to the option award shall vest on December 8, 2026 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.